Home › Therapeutic areas › Neurology › Parkinson's Disease
Parkinson's Disease (7 companies)
Companies with an active program in Parkinson's Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ATHE | ALTERITY THERAPEUTICS LTD | Neurology Rare | 1 | Phase 2 | 2 |
| ARVN | ARVINAS, INC. | NeurologyOncology Rare | 1 | Approved | 15 |
| CLNN | Clene Inc. | Neurology Rare | 1 | NDA Submitted | 5 |
| GANX | Gain Therapeutics, Inc. | MetabolicNeurology Rare | 2 | Phase 1 | 5 |
| OMER | OMEROS CORP | HematologyNeurologyOncologyRespiratory Rare | 1 | NDA Submitted | 7 |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | CardiovascularDermatologyNeurologyRespiratory Rare | 1 | Phase 3 | 10 |
| VYGR | Voyager Therapeutics, Inc. | MetabolicNeurology Rare | 1 | Phase 1 | 7 |
No companies match.